Purpose

The purpose of this clinical trial is to learn about the Tremor Retrainer smartphone application and Simplified Functional Movement Disorder Rating Scale in patients with functional tremor. The main questions the study aims to answer are: 1. Is the Tremor Retrainer application usable for patients and are there signs that it can help functional tremor? 2. Can a televideo administration of the Simplified Functional Movement Disorder Rating Scale give enough information to use this scale via televideo in future studies?

Conditions

Eligibility

Eligible Ages
Over 10 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Age 10 years and older, any gender, any race 2. Functional tremor as defined by Espay and Lang25, diagnosed by a movement disorders neurologist, involving at least 1 arm and ongoing at time of enrollment. 3. Access to internet and a laptop or tablet with a videocamera. 4. Informed consent obtained and signed 5. Subject understands study procedures and is able to comply with study procedures for duration of study

Exclusion Criteria

  1. Parkinson's disease, essential tremor, or other disorders causing involuntary movements in addition to functional tremor 2. Cognitive impairment with previously diagnosed intellectual disability (IQ<70) or dementia 3. Hearing impairment not addressed by hearing aids 4. Prior enrollment in clinical trial involving the Tremor Retrainer application

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Intervention Arm
All subjects will receive intervention with Tremor Retrainer smartphone application
  • Device: Tremor Retrainer Smartphone Application
    The Tremor Retrainer smartphone application uses the smartphone's built-in accelerometer to calculate a patient's tremor frequency when the smartphone is strapped to the patient's wrist. The application will provide auditory cues to the patient with a treatment frequency at 2/3 the patient's baseline tremor frequency for half a session, then 1/3 the patient's baseline tremor frequency for the second half of the session. Meanwhile, oscillatory movements will be continuously analyzed with frequency calculated and displayed relative to goal frequency, so that the patient receives continuous feedback via a visual dial as to whether they are meeting treatment goals. Intervention will consist of a one-week Tremor Retrainment Protocol.

Recruiting Locations

University of Virginia
Charlottesville, Virginia 22903
Contact:
Hannah Caballero, LCSW
434-297-5711
HTP5AW@uvahealth.org

More Details

NCT ID
NCT06257069
Status
Recruiting
Sponsor
University of Virginia

Study Contact

Hannah Caballero, LCSW
434-297-5711
HTP5AW@uvahealth.org

Detailed Description

Following a one-week observation period, 20 subjects will complete the one-week four hour Tremor Retrainer smartphone protocol. The study will consist of 4 in-person visits over 3-4 months and one televideo visit the same day as study visit 1. For Objective 1, the investigators will evaluate mHealth Application Usability Questionnaire scores after subjects complete Tremor Retrainer protocol and compare Simplified Functional Movement Disorder Rating Scale (S-FMDRS) scores before (study visit 2) and after (study visits 3 and 4) intervention between groups. For Objective 2, the investigators will evaluate which components can be scored after televideo administration of S-FMDRS and measure correlation between randomly-ordered sequential in-person and televideo S-FMDRS administration. For Objective 3, the investigators will measure change and variability in S-FMDRS between study visit 1 and 2. S-FMDRS scoring will be completed via video review by a movement disorder neurologist blinded to timing of visit relative to treatment.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.